Clinical significance of frontal cortex abnormalities in Huntington's disease

Experimental Neurology

Volumn 247, Issue , 2013, Pages 39-44

  Wolf, Robert Christian ^a   Klöppel, Stefan ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Clinical relevance; FMRI; Huntington's disease; Psychiatric symptoms

Indexed keywords

APATHY; ASYMPTOMATIC DISEASE; BRAIN DYSFUNCTION; BRAIN FUNCTION; BRAIN REGION; CELL LOSS; CLINICAL FEATURE; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DEPRESSION; ELECTROENCEPHALOGRAM; EXECUTIVE FUNCTION; FRONTAL CORTEX; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE CONTROL; GENE MUTATION; HETEROZYGOTE; HUMAN; HUNTINGTON CHOREA; IRRITABILITY; MENTAL DETERIORATION; NERVE CELL DIFFERENTIATION; NONHUMAN; NOTE; PRIORITY JOURNAL; STEADY STATE;

CLINICAL RELEVANCE; FMRI; HUNTINGTON'S DISEASE; PSYCHIATRIC SYMPTOMS;

COGNITION; FEMALE; HUMANS; HUNTINGTON DISEASE; MALE; MENTAL DISORDERS; PREFRONTAL CORTEX;

EID: 84876708022     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2013.03.022     Document Type: Note

References (76)

1. Abdulkadir A., Ronneberger O., Wolf R.C., Pfleiderer B., Saftf C., Klöppel S. Functional and structural MRI biomarkers to detect pre-clinical neurodegeneration. Curr. Alzheimer Res. 2013, 10(2):125-134. (Feb 1).
2. Alexopoulos G.S., Hoptman M.J., Yuen G., Kanellopoulos D.K., Seirup J., Lim K.O., Gunning F.M. Functional connectivity in apathy of late-life depression: A preliminary study. J. Affect. Disord. 2012, (Dec 19, pii: S0165-0327(12)00776-8, in press).
3. Bhide P.G., Day M., Sapp E., Schwarz C., Sheth A., Kim J., Young A.B., Penney J., Golden J., Aronin N., et al. Expression of normal and mutant huntingtin in the developing brain. J. Neurosci. 1996, 16:5523-5535.
4. Bohanna I., Georgiou-Karistianis N., Egan G.F. Connectivity-based segmentation of the striatum in Huntington's disease: vulnerability of motor pathways. Neurobiol. Dis. 2011, 42:475-481.
5. Bohanna I., Georgiou-Karistianis N., Sritharan A., Asadi H., Johnston L., Churchyard A., Egan G. Diffusion tensor imaging in Huntington's disease reveals distinct patterns of white matter degeneration associated with motor and cognitive deficits. Brain Imaging Behav. 2011, 5:171-180.
6. Clark V.H., Resnick S.M., Doshi J., Beason-Held L.L., Zhou Y., Ferrucci L., Wong D.F., Kraut M.A., Davatzikos C. Longitudinal imaging pattern analysis (SPARE-CD index) detects early structural and functional changes before cognitive decline in healthy older adults. Neurobiol. Aging 2012, 33:2733-2745.
7. Davatzikos C., Xu F., An Y., Fan Y., Resnick S.M. Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index. Brain 2009, 132:2026-2035.
8. Drevets W.C., Savitz J., Trimble M. The subgenual anterior cingulate cortex in mood disorders. CNS Spectr. 2008, 13:663-681.
9. Duyao M.P., Auerbach A.B., Ryan A., Persichetti F., Barnes G.T., McNeil S.M., Ge P., Vonsattel J.P., Gusella J.F., Joyner A.L. Inactivation of the mouse Huntington's disease gene homolog Hdh. Science 1995, 269:407-410.
10. Ferrante R.J., Gutekunst C.A., Persichetti F., McNeil S.M., Kowall N.W., Gusella J.F., MacDonald M.E., Beal M.F., Hersch S.M. Heterogeneous topographic and cellular distribution of huntingtin expression in the normal human neostriatum. J. Neurosci. 1997, 17:3052-3063.
11. Georgiou-Karistianis N., Gray M.A., Domínguez D J.F., Dymowski A.R., Bohanna I., Johnston L.A., Churchyard A., Chua P., Stout J.C., Egan G.F. Automated differentiation of pre-diagnosis Huntington's disease from healthy control individuals based on quadratic discriminant analysis of the basal ganglia: the IMAGE-HD study. Neurobiol. Dis. 2012.
12. Gómez-Ansón B., Alegret M., Muñoz E., Monté G.C., Alayrach E., Sánchez A., Boada M., Tolosa E. Prefrontal cortex volume reduction on MRI in preclinical Huntington's disease relates to visuomotor performance and CAG number. Parkinsonism Relat. Disord. 2009, 15:213-219.
13. Gray M.A., Egan G.F., Ando A., Churchyard A., Chua P., Stout J.C., Georgiou-Karistianis N. Prefrontal activity in Huntington's disease reflects cognitive and neuropsychiatric disturbances: the IMAGE-HD study. Exp. Neurol. 2012, 239C:218-228.
14. Gutekunst C.A., Li S.H., Yi H., Mulroy J.S., Kuemmerle S., Jones R., Rye D., Ferrante R.J., Hersch S.M., Li X.J. Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology. J. Neurosci. 1999, 19:2522-2534.
15. Hasselbalch S.G., Oberg G., Sørensen S.A., Andersen A.R., Waldemar G., Schmidt J.F., Fenger K., Paulson O.B. Reduced regional cerebral blood flow in Huntington's disease studied by SPECT. J. Neurol. Neurosurg. Psychiatr. 1992, 55:1018-1023.
16. Henley S.M.D., Wild E.J., Hobbs N.Z., Scahill R.I., Ridgway G.R., Macmanus D.G., Barker R.A., Fox N.C., Tabrizi S.J. Relationship between CAG repeat length and brain volume in premanifest and early Huntington's disease. J. Neurol. 2009, 256:203-212.
17. Hennenlotter A., Schroeder U., Erhard P., Haslinger B., Stahl R., Weindl A., Von Einsiedel H.G., Lange K.W., Ceballos-Baumann A.O. Neural correlates associated with impaired disgust processing in pre-symptomatic Huntington's disease. Brain 2004, 127:1446-1453.
18. Hickey M.A., Chesselet M.-F. The use of transgenic and knock-in mice to study Huntington's disease. Cytogenet. Genome Res. 2003, 100:276-286.
19. Ichise M., Toyama H., Fornazzari L., Ballinger J.R., Kirsh J.C. Iodine-123-IBZM dopamine D2 receptor and technetium-99m-HMPAO brain perfusion SPECT in the evaluation of patients with and subjects at risk for Huntington's disease. J. Nucl. Med. 1993, 34:1274-1281.
20. Julien C.L., Thompson J.C., Wild S., Yardumian P., Snowden J.S., Turner G., Craufurd D. Psychiatric disorders in preclinical Huntington's disease. J. Neurol. Neurosurg. Psychiatry 2007, 78:939-943.
21. Klöppel S. Brain morphometry and functional imaging techniques in dementia: methods, findings and relevance in forensic neurology. Curr. Opin. Neurol. 2009, 22:612-616.
22. Klöppel S., Draganski B., Golding C.V., Chu C., Nagy Z., Cook P.A., Hicks S.L., Kennard C., Alexander D.C., Parker G.J., et al. White matter connections reflect changes in voluntary-guided saccades in pre-symptomatic Huntington's disease. Brain 2008, 131:196-204.
23. Klöppel S., Henley S.M., Hobbs N.Z., Wolf R.C., Kassubek J., Tabrizi S.J., Frackowiak R.S. Magnetic resonance imaging of Huntington's disease: preparing for clinical trials. Neuroscience 2009, 164:205-219.
24. Klöppel S., Chu C., Tan G.C., Draganski B., Johnson H., Paulsen J.S., Kienzle W., Tabrizi S.J., Ashburner J., Frackowiak R.S. Automatic detection of preclinical neurodegeneration: presymptomatic Huntington disease. Neurology 2009, 72:426-431.
25. Klöppel S., Draganski B., Siebner H.R., Tabrizi S.J., Weiller C., Frackowiak R.S. Functional compensation of motor function in pre-symptomatic Huntington's disease. Brain 2009, 132:1624-1632.
26. Klöppel S., Stonnington C.M., Petrovic P., Mobbs D., Tüscher O., Craufurd D., Tabrizi S.J., Frackowiak R.S.J. Irritability in pre-clinical Huntington's disease. Neuropsychologia 2010, 48:549-557.
27. Klöppel S., Abdulkadir A., Jack C.R., Koutsouleris N., Mourão-Miranda J., Vemuri P. Diagnostic neuroimaging across diseases. NeuroImage 2012, 61:457-463.
28. Laforet G.A., Sapp E., Chase K., McIntyre C., Boyce F.M., Campbell M., Cadigan B.A., Warzecki L., Tagle D.A., Reddy P.H., et al. Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease. J. Neurosci. 2001, 21:9112-9123.
29. Lawrence A.D., Goerendt I.K., Brooks D.J. Apathy blunts neural response to money in Parkinson's disease. Soc. Neurosci. 2011, 6:653-662.
30. Manoach D.S., Schlaug G., Siewert B., Darby D.G., Bly B.M., Benfield A., Edelman R.R., Warach S. Prefrontal cortex fMRI signal changes are correlated with working memory load. Neuroreport 1997, 8:545-549.
31. Marrakchi-Kacem L., Delmaire C., Guevara P., Poupon F., Lecomte S., Tucholka A., Roca P., Yelnik J., Durr A., Mangin J.-F., et al. Mapping cortico-striatal connectivity onto the cortical surface: a new tractography-based approach to study Huntington disease. PLoS One 2013, 8:e53135.
32. Mayberg H.S., Starkstein S.E., Peyser C.E., Brandt J., Dannals R.F., Folstein S.E. Paralimbic frontal lobe hypometabolism in depression associated with Huntington's disease. Neurology 1992, 42:1791-1797.
33. Miller E.K. The prefrontal cortex and cognitive control. Nat. Rev. Neurosci. 2000, 1:59-65.
34. Miller E.K., Cohen J.D. An integrative theory of prefrontal cortex function. Annu. Rev. Neurosci. 2001, 24:167-202.
35. Mourão-Miranda J., Hardoon D.R., Hahn T., Marquand A.F., Williams S.C.R., Shawe-Taylor J., Brammer M. Patient classification as an outlier detection problem: an application of the One-Class Support Vector Machine. NeuroImage 2011, 58:793-804.
36. Naarding P., Janzing J.G.E., Eling P., Van der Werf S., Kremer B. Apathy is not depression in Huntington's disease. J. Neuropsychiatr. Clin. Neurosci. 2009, 21:266-270.
37. Nasir J., Floresco S.B., O'Kusky J.R., Diewert V.M., Richman J.M., Zeisler J., Borowski A., Marth J.D., Phillips A.G., Hayden M.R. Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell 1995, 81:811-823.
38. Nopoulos P.C., Aylward E.H., Ross C.A., Mills J.A., Langbehn D.R., Johnson H.J., Magnotta V.A., Pierson R.K., Beglinger L.J., Nance M.A., et al. Smaller intracranial volume in prodromal Huntington's disease: evidence for abnormal neurodevelopment. Brain 2011, 134:137-142.
39. Novak M.J.U., Warren J.D., Henley S.M.D., Draganski B., Frackowiak R.S., Tabrizi S.J. Altered brain mechanisms of emotion processing in pre-manifest Huntington's disease. Brain 2012, 135:1165-1179.
40. Orth M., Schippling S., Schneider S.A., Bhatia K.P., Talelli P., Tabrizi S.J., Rothwell J.C. Abnormal motor cortex plasticity in premanifest and very early manifest Huntington disease. J. Neurol. Neurosurg. Psychiatr. 2010, 81:267-270.
41. Papp K.V., Kaplan R.F., Snyder P.J. Biological markers of cognition in prodromal Huntington's disease: a review. Brain Cogn. 2011, 77:280-291.
42. Paulsen J.S., Magnotta V.A., Mikos A.E., Paulson H.L., Penziner E., Andreasen N.C., Nopoulos P.C. Brain structure in preclinical Huntington's disease. Biol. Psychiatry 2006, 59:57-63.
43. Paulsen J.S., Nopoulos P.C., Aylward E., Ross C.A., Johnson H., Magnotta V.A., Juhl A., Pierson R.K., Mills J., Langbehn D., et al. Striatal and white matter predictors of estimated diagnosis for Huntington disease. Brain Res. Bull. 2010, 82:201-207.
44. Raichle M.E., MacLeod A.M., Snyder A.Z., Powers W.J., Gusnard D.A., Shulman G.L. A default mode of brain function. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:676-682.
45. Reid I.C., Besson J.A., Best P.V., Sharp P.F., Gemmell H.G., Smith F.W. Imaging of cerebral blood flow markers in Huntington's disease using single photon emission computed tomography. J. Neurol. Neurosurg. Psychiatr. 1988, 51:1264-1268.
46. Robert G., Le Jeune F., Lozachmeur C., Drapier S., Dondaine T., Péron J., Travers D., Sauleau P., Millet B., Vérin M., et al. Apathy in patients with Parkinson disease without dementia or depression: a PET study. Neurology 2012, 79:1155-1160.
47. Rosas H.D., Hevelone N.D., Zaleta A.K., Greve D.N., Salat D.H., Fischl B. Regional cortical thinning in preclinical Huntington disease and its relationship to cognition. Neurology 2005, 65:745-747.
48. Rosas H.D., Salat D.H., Lee S.Y., Zaleta A.K., Pappu V., Fischl B., Greve D., Hevelone N., Hersch S.M. Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity. Brain 2008, 131:1057-1068.
49. Ruocco H.H., Bonilha L., Li L.M., Lopes-Cendes I., Cendes F. Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat. J. Neurol. Neurosurg. Psychiatry 2008, 79:130-135.
50. Rypma B., D'Esposito M. The roles of prefrontal brain regions in components of working memory: effects of memory load and individual differences. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:6558-6563.
51. Sapp E., Schwarz C., Chase K., Bhide P.G., Young A.B., Penney J., Vonsattel J.P., Aronin N., DiFiglia M. Huntingtin localization in brains of normal and Huntington's disease patients. Ann. Neurol. 1997, 42:604-612.
52. Savitz J., Drevets W.C. Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide. Neurosci. Biobehav. Rev. 2009, 33(5):699-771. (May).
53. Sax D.S., Powsner R., Kim A., Tilak S., Bhatia R., Cupples L.A., Myers R.H. Evidence of cortical metabolic dysfunction in early Huntington's disease by single-photon-emission computed tomography. Mov. Disord. 1996, 11:671-677.
54. Scheller E., Abdulkadir A., Peter J., Tabrizi S.J., Frackowiak R.S., Klöppel S. Interregional compensatory mechanisms of motor functioning in progressing preclinical neurodegeneration. NeuroImage 2013, 75C:146-154. (Mar 14, Epub ahead of print). 10.1016/j.neuroimage.2013.02.058.
55. Schippling S., Schneider S.A., Bhatia K.P., Münchau A., Rothwell J.C., Tabrizi S.J., Orth M. Abnormal motor cortex excitability in preclinical and very early Huntington's disease. Biol. Psychiatry 2009, 65:959-965.
56. Simon J.J., Biller A., Walther S., Roesch-Ely D., Stippich C., Weisbrod M., Kaiser S. Neural correlates of reward processing in schizophrenia-relationship to apathy and depression. Schizophr. Res. 2010, 118:154-161.
57. Sprengelmeyer R., Müller H.P., Süssmuth S., Groen G., Cole J., Hobbs N., Roos R., Dürr A., Tabrizi S., Landwehrmeyer B., et al. The neuroanatomy of depression: evidence from Huntington's disease. (Stockholm) 2012.
58. Stoffers D., Sheldon S., Kuperman J.M., Goldstein J., Corey-Bloom J., Aron A.R. Contrasting gray and white matter changes in preclinical Huntington disease: an MRI study. Neurology 2010, 74:1208-1216.
59. Sturm W., Willmes K. On the functional neuroanatomy of intrinsic and phasic alertness. NeuroImage 2001, 14:S76-S84.
60. Teipel S.J., Born C., Ewers M., Bokde A.L., Reiser M.F., Moller H.J., Hampel H. Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment. NeuroImage 2007, 38:13-24.
61. Théberge J. Perfusion magnetic resonance imaging in psychiatry. Top. Magn. Reson. Imaging 2008, 19:111-130.
62. Van den Heuvel M.P., Hulshoff Pol H.E. Exploring the brain network: a review on resting-state fMRI functional connectivity. Eur. Neuropsychopharmacol. 2010, 20:519-534.
63. Van Duijn E., Kingma E.M., Van der Mast R.C. Psychopathology in verified Huntington's disease gene carriers. J. Neuropsychiatry Clin. Neurosci. 2007, 19:441-448.
64. Walker F.O. Huntington's disease. Lancet 2007, 369:218-228.
65. Weeks R.A., Ceballos-Baumann A., Piccini P., Boecker H., Harding A.E., Brooks D.J. Cortical control of movement in Huntington's disease. A PET activation study. Brain 1997, 120(9):1569-1578.
66. Westman E., Simmons A., Zhang Y., Muehlboeck J.-S., Tunnard C., Liu Y., Collins L., Evans A., Mecocci P., Vellas B., et al. Multivariate analysis of MRI data for Alzheimer's disease, mild cognitive impairment and healthy controls. NeuroImage 2011, 54:1178-1187.
67. Wolf R.C., Walter H. Evaluation of a novel event-related parametric fMRI paradigm investigating prefrontal function. Psychiatry Res. 2005, 140:73-83.
68. Wolf R.C., Vasic N., Schonfeldt-Lecuona C., Landwehrmeyer G.B., Ecker D. Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fMRI. Brain 2007, 130:2845-2857.
69. Wolf R.C., Sambataro F., Vasic N., Schonfeldt-Lecuona C., Ecker D., Landwehrmeyer B. Altered frontostriatal coupling in pre-manifest Huntington's disease: effects of increasing cognitive load. Eur. J. Neurol. 2008, 15:1180-1190.
70. Wolf R.C., Sambataro F., Vasic N., Schonfeldt-Lecuona C., Ecker D., Landwehrmeyer B. Aberrant connectivity of lateral prefrontal networks in presymptomatic Huntington's disease. Exp. Neurol. 2008, 213:137-144.
71. Wolf R.C., Vasic N., Schonfeldt-Lecuona C., Ecker D., Landwehrmeyer G.B. Cortical dysfunction in patients with Huntington's disease during working memory performance. Hum. Brain Mapp. 2009, 30:327-339.
72. Wolf R.C., Sambataro F., Vasic N., Wolf N.D., Thomann P.A., Landwehrmeyer G.B., Orth M. Longitudinal functional magnetic resonance imaging of cognition in preclinical Huntington's disease. Exp. Neurol. 2011, 231:214-222.
73. Wolf R.C., Thomann P.A., Thomann A.K., Vasic N., Wolf N.D., Landwehrmeyer G.B., Orth M. Brain structure in preclinical Huntington's disease: a multi-method approach. Neurodegener. Dis. 2012, (Aug 17, Epub ahead of print).
74. Wolf R.C., Sambataro F., Vasic N., Wolf N.D., Thomann P.A., Saft C., Landwehrmeyer G.B., Orth M. Default-mode network changes in preclinical Huntington's disease. Exp. Neurol. 2012, 237:191-198.
75. Zamboni G., Huey E.D., Krueger F., Nichelli P.F., Grafman J. Apathy and disinhibition in frontotemporal dementia: insights into their neural correlates. Neurology 2008, 71:736-742.
76. Zeitlin S., Liu J.P., Chapman D.L., Papaioannou V.E., Efstratiadis A. Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nat. Genet. 1995, 11:155-163.